Posted by: Audrey Erbes | May 22, 2016

This Week’s Bay Area Bioscience Meetings

Upcoming Bay Area Meetings Week of May 23, 2016

  • Bio2Device Group, Tuesday Morning, May 24, 2016; Topic: “Green Chemistry Global Adoption: Its challenges, advances and opportunities;” Speakers: Neelam Vaidya and Jose Castanon , CEO and Marketing Executive, ViridisChem Inc.
  • BioScience Forum, Wednesday Evening, May 25, 2016; Topic: “Recent Trends in the Biopharma Financing and Licensing Market;” Speaker: Chris Ehrlich, Managing Director , Locust Walk Partners
  • HBA, Thursday Evening, May 26, 2016; Event: “HB8 Dine-Around: The State of International Women’s Health Today with Sally Stephens;” Featured speaker: Sally Stephens, Senior vice president, corporate development, Medicines360
  • WIB Webinar, Thursday Afternoon, May 26, 2016; National Webinar: “Raising Capital for Rising Companies;” Heather Smith, Managing Director, Head of Private Financing Solutions, Sagent Advisors
  • Rosenman Institute, Thursday Early Evening, May 26, 2016; Topic: “D-Series:How to Commercialize and Scale Your Product for Global Health Markets;” Speaker: Krista Donaldson, CEO of D-Rev. “Brilliance”

You can download details for the above events in a complete PDF list of upcoming events through August 2016 by right clicking on Audreys Picks May 22, 2016. You can also download JobsThatCrossedMyDeskThrough May 22, 2016.

Audrey

Posted by: Audrey Erbes | May 15, 2016

Upcoming Bioscience Meetings in Bay Area

I haven’t been writing comments each week lately as I spend more time attending industry meetings and trying to make sense out of the crazy political arena. There is so much to be done in the community to save our community vitality as well as vibrancy for careers for professionals in life science.

I am looking for my new mission is life. I’ve been asked to try mentoring young professionals in a local biotech. I’m open to any ideas those of you you know me might have. You know I never let the moss grow under my feet!

Highlights of Bay Area Bioscience Meetings Week of May 15, 2016

  • Bio2Device Group, Tuesday Morning, May 17, 2016; Topic: “Early Stage Funding – Alternative Approaches for the Traditional Life Science Company;” Speaker: Austin Walker, Co-Founder & CEO
  • NCC-AWIS, Tuesday Evening, May 17, 2016; Event: Annual Awards and Recognition Banquet; Keynote Address Speaker: Susanne Lindgren, PhD, professor at Cal State University, Sacramento and was the 2015 Judith Pool Award recipient.
  • BioPharmaPM, Wednesday, May 18, 2016; Event: Leadership, & Technical Project Management: Leveraging the PMI Talent Triangle in BioPharma””
  • EMBS, Wednesday Evening, May 18, 2016; Topic: “Digital Medicines Provide Physicians With Insights into Patient Medication-taking Patterns and Physiologic Response, Enabling Efficient Therapy Optimization;” Speaker: Mark J. Zdeblick, Ph.D., Co-Founder, Chief Technology Officer, Proteus Digital Health, Inc.
  • GGPF Dinner, Wednesday Evening, May 18, 2016; Lecture: “Polymer and Mixed-Matrix Membranes for Gas Separations;” Speaker: Dr. Zachary P. Smith, Department of Chemistry,University of California, Berkeley
  • JLABS, Thursday, May 19, 2016; Event: “WORKSHOP 3 | Lessons Learned: The IPO process from battle tested Veterans;” Speakers: Linda Bain | Chief Financial Officer, Codiak BioSciences; Isaac Ciechanover | President & CEO, Atara Biotherapeutics;[moderator] Angela Rusakova | West Region Life Sciences Audit Partner, Deloitte & Touche LLP
  • QB3, Thursday Mid Day, May 19, 2016; Topic: “How to Navigate US Immigration Law for Biotech Entrepreneurs;” Speakers: Norman Plotkin and Atessa Chehrazi, partners at the immigration law firm of Jackson & Hertogs
  • Clark Seminar, Thursday Mid Day, May 19, 2016; Event: In vitro Vascularized Constructs as Models of Metastatic Cancer
  • ACRP Northern California Chapter, Thursday Evening, May 19, 2016; Topic: Spotlight on Site/Sponsor Collaborations: Soutions to 5 Key Issues; Speaker: Christine Pierre, President, Society for Clinical Research Sites
  • BioPharma Consortium, Friday Morning, May 20, 2016; BioPharma Consortium Breakfast Briefing: Must-Know Finance Concepts for Life Sciences Valuations: Good, Bad, & Most Effective; Speaker: John Selig, Co-Founder and Managing Partner, Mavericks CapitaDate

You can download details for the above events in a complete PDF list of upcoming events through August 2016 by right clicking onAudreys Picks May 15, 2016. JobsThatCrossedMyDeskThrough May 15, 2016are also available in PDF list.

Audrey

 

 

Posted by: Audrey Erbes | May 8, 2016

Bay Area Life Science Meetings Week of May 8, 2016

Highlights of Upcoming Bay Area Bioscience Events Week of May 8, 2016

  • Bio2Device Group, Tuesday Evening, May 10, 2016; Topic: Is discovery research a luxury or a necessity in biotech? Speaker: Austin Gurney, Ph.D, CSO, Senior VP, Molecular and Cellular Biology, Oncomed
  • sfAWIS, Tuesday Evening, May 10, 2016; Topic: “The Conflict Shift: from Conflict to Cooperation;” Speaker: Susan Bernstein, MBA, PhD, Executive Coach and Leadership Training
  • RAPS, Wednesday Afternoon, May 11, 2016; Topic: “Navigating US Market Access Landscape for Optimal Regulatory and Business Strategy;” Speaker: Speaker:Jane Horvath, MHSA, market access lead, 3D Communiations
  • WIB, Wednesday Evening, May 11, 2016; Event: “Speed Networking at Molecular Devices”
  • HBA San Francisco, Thursday Morning, May 12, 2016; Event: “2016 Woman of Year Event – West”
  • EPPIC and Genentech, Friday MidDay, May 13, 2016; Event: Global Perspectives for Payer Evidence and Impact on Pricing and Access; Speakers: Brian O’Shea and Jeff Hille
  • Stanford Medicine, Saturday, May 14, 2016; Topic: “Health Matters 2016”

You can download details for the above events in a complete PDF list of upcoming events through August 2016 by right clicking on Audreys Picks May 8, 2016. JobsThatCrossedMyDeskThrough May 8, 2016 are also available in PDF list.

Audrey

Highlights of Bay Area Bioscience Events Week of May 1, 2016

  • BioDesign at Stanford, Monday Evening, May 2, 2016; Event: “Stanford Biodesign, 15 Years of Innovation: Past, Present and Future Perspectives;” Impressive list of speakers on panel
  • Bio2Device Group, Tuesday Morning, May 3, 2016; Topic: “Launching telemedicine devices abroad: a case study in CV;” Speakers: Srikanth Jadcherla, Professor and Chairman of the Board, Global Technology University, Chairman of the Board, Piitech Inc. and Dr. Rich Goldman, Chief Marketing Officer, PiiTech
  • ASQ, Wednesday Evening, April 27, 2016, Event: Medical Device Cybersecurity (including Device Software Interoperability); Speaker: Dr. Geetha Rao, CEO of Springborne Life Sciences
  • BMES Industry Group: San Francisco/Bay Area, Tuesday Evening, May 3, 2016; Topic: “What Should Healthcare Innovation in Emerging Markets Be Focused On: New Product Ideas or Market Development?” Speaker: Dr. Anurag Mairal, MedTech Innovator, Academic, Entrepreneur
  • Stanford Law Program in Law, Science and Technology, Wednesday, May 4, 2016; Event: Stanford IP Law And The Biosciences Conference; Confirmed Speakers: Victoria Brewster, Fisherbroyles, Llp; Trevor Cook, Wilmerhale; John Duffy, University Of Virginia School Of Law; Rebecca Eisenberg, University Of Michigan Law School; Deborah Fishman, Kaye Scholer; Hon. Arthur Gajarsa, Formerly United States Court Of Appeals For The Federal Circuit; Wilmerhale; Robert Galvin, Wilmerhale; Hon. Paul Singh Grewal, United States District Court For The Northern District Of California; Hon. Faith Hochberg, Formerly, United States District Court For The District Of New Jersey;Hon. Susan Illston, United States District Court For The Northern District Of California; William “Bill” Lee, Wilmerhale; Mark Lemley, Durie Tangri Llp; Stanford Law School; Michael Lisi, Ariosa Diagnostics; Lisa Larrimore Ouellette, Stanford Law School; Arti Rai, Duke University School Of Law; Hon. James Selna, United States District Court For The Central District Of California; Hon. Gregory Sleet, United States District Court For The District Of Delaware; Laura Storto, Genentech; John “Jay” Thomas, Georgetown Law
  • qb3, Thursday MidDay, May 5, 2016, QB3 Spring 2016 NSF SBIR Bootcamp
  • Bio-X, Saturday, May 7, 2016; “In vitro Vascularized Constructs as Models of Metastatic Cancer”
  • CABS, Saturday, May 7, 2017; Event: 2016 BioPacific Conference

You can download details for the above events in a complete PDF list of upcoming events through August 2016 by right clicking on Audreys Picks May 1, 2016s.

Audrey

 

 

 

Posted by: Audrey Erbes | April 25, 2016

Upcoming Bioscience Events in Bay Area

Highlights of Upcoming Bay Area Life Science Events

  • Bio2Device Group, Tuesday Morning, April 26, 2016; Topic: “The Ever Changing Startup Environment;” Speaker: Jeffrey J Christian , CEO, Phoenix DeVentures Inc.
  • Bio-X Frontiers, Tuesday, April 26, 2016; Topic: “Integration Of Systems Biology, Tissue Engineering, And Microdevices For Drug Development;” Pre-Seminar Speaker: Ovijit Chaudhuri, Department Of Mechanical Engineering; Seminar Speaker: Linda Griffith, Mit –Integration Of Systems Biology, Tissue Engineering, And Microdevices For Drug Development
  • HBA, Tuesday Evening, April 26, 2016; Event: HBA Dine-Around: The State of International Women’s Health Today; Speaker: Sally Stephens, Senior vice president, corporate development, Medicines360
  • Qb3, Tuesday Mid Day, April 26, 2016; Topic: “Investment Themes in the New Healthcare Marketplace;” Speaker: Nina Kjellson, General Partner, VC firm Canaan Partners
  • Naturejobs Career Expo, Wednesday, April 27,2016; Event: Career Expo
  • WIB-San Francisco Bay Area, Wednesday Evening, April 27, 2016; Topic: “Making the Transition from Academia to Industry;” Panel: Moderator: Maya Benbarak (Genentech) and feature speakers Rebecca Begley (Gilead), Ellen Shen (Gilead), Linda Yu (23andMe), and Jess Porter Abate (Roche).
  • BioScience Forum, Wednesday Evening, April 27, 2016; Topic: “Discovery of GDC-0853: A Highly Potent, Selective and Non-Covalent Btk Inhibitor;” Speaker: Wendy Young, Ph.D., Vice President of Discovery Chemistry, Genentech

You can download details for the above events in a complete PDF list of upcoming events through August 2016 by right clicking on Audreys Picks April 24, 2016.

Audrey

Posted by: Audrey Erbes | April 17, 2016

2015 IMS U.S. Drug Spending Growth Report

2015 IMS Drug Spending Growth

Recently released IMS Health Study: “U.S. Drug Spending Growth Reaches 8.5 Percent in 2015” (April 14, 2016) isn’t surprising to those following the market.  That growth was based on total spending of $310 billion in the US resulting from rebates and other price concessions.  (Invoice-based spending was $425 billion.) Savings from new generics of branded drugs was low.  Price increases on brands was limited due to higher rebates and price concessions from manufacturers. Latter seems to be learning that they can’t continue price increases on marketed brands as they did in past.

Cost of specialty drugs increased dramatically and nearly doubled in the last 5 years and patients have seen growth in out-of-pocket expenses as well as access barriers to certain medicines. There was 21.5 percent increase in specialty drug spending to $150.8 billion on invoice price basis in 2015.This is no surprise. Pharma companies have been learning that providers  are looking for rebates and other cost savings to keep total prescription cost down for their covered lives but they try to pass those costs on to patient.

New Active Substances reached 43 in 2015 and these had much higher price tags than past new medicines.  14 non-orphan with new mechanisms of action entered market. New active substance drug launches were notable advances in precision medicines, rare disease therapeutics and chronic disease medicines that could benefit large populations.

The average patient cost exposure for brand prescriptions filled through a commercial plan has increased more than 25 percent since 2010, reaching $44 per prescription last year. We would expect that the population might blame higher costs on Obamacare when it’s actually the impact of higher priced new breakthrough drugs.

See details of above at http://www.imshealth.com/en/about-us/news/ims-health-study-us-drug-spending-growth-reaches-8.5-percent-in-2015

The full version of the report, including a detailed description of the methodology, is available at www.theimsinstitute.org. It can also be downloaded as an app via iTunes athttps://itunes.apple.com/app/ims-institute/id625347542.The study was produced independently as a public service, without industry or government funding.

Overview of Upcoming Bay Area Life Science Meetings

  • Bio2Device Group, Tuesday Morning, April 19, 2016; Topic: “Women’s Sexual Wellness in 2016: Can Great Medical Products Change the Conversation?” Speaker: Holly Rockweiler, CEO & Co-Founder, Madorra
  • JLABS, Wednesday, April 20, 2016; Event: WORKSHOP 2 | IPO Readiness Bootcamp | April 20
  • EMBS, Wednesday Evening, April 20, 2016; Topic: “;” Speaker: Jonathan Sorger, Sr. Director of Medical Research, Intuitive Surgical, Inc.
  • West Coast Chapter PDA, Thursday, April 21, 2016; Event: “Women in the Biopharmaceutical Industry: A Panel Discussion and Networking with Company Leaders”
  • BioPharma Consortium, Friday, April 22, 2016;Topic: “How to Develop a Winning Patent Portfolio;” Speakers: John Storella, Intellectual Property Law For Innovators In Biotechnology and Shirley Recipon, Life Science and Intellectual Property Professional

You can download details for the above events in a complete PDF list of upcoming events through August 2016 by right clicking on Audreys Picks April 17, 2016 A list of jobs is included in JobsThatCrossedMyDeskThrough April 17, 2016.

Audrey

 

Posted by: Audrey Erbes | April 10, 2016

New Treasury Rules Stop Pfizer- Allergan Merger

  • New Treasury Rules Halt Pfizer Attempt at Tax Saving InversionPfizer and Allergan have stopped a $160 billion merger as a result of new Treasury rules that would make the plan less lucrative. If merger had gone through, Pfizer would not have moved its address. The objective was to lower corporate taxes of about $two billion dollars in the U.S. per year with Allergan merger. See http://time.com/4124633/pfizer-allergan-merger-taxes-inversion/. With recent exposure of “Panama Papers” sharing information about hiding assets offshore, the inversion movement by large American corporations to cut taxes in not surprising. I just don’t understand how corporate financial strategists don’t see that they are attempting to use “legal” acts to achieve morally illegal goals.

    I shake my head wondering where this infusion of lack of ethics has entered our business life so wholesale. It has become central to successful business operations. Amerian corporations have placed their shareholders’ financial gain ahead of all other community values or virtues.

    Greed now seems to be imbedded in American business. I look forward to seeing a study that shows if present MBA programs are behind this development among financial professionals and investors and venture capitalists. Or is it running rampant among the population at large.

  • Highlights of Upcoming Week’s Bay Area Events
    • QB3, Tuesday Mid Day, April 12, 2016: Topic: “Friends in Low Places: How I Leveraged Everyone I Know to Start a Company;” Speaker: Colleen Cutcliffe, Whole Biome.
    • Bio2Device Group, Tuesday Evening, April 12, 2016; Topic: “Understanding the Hidden But Knowable Pitfalls in Realizing the Full Potential of Your Medical Technology;” Speaker: Joseph Galatowitsch, President, Dymedex Consulting, LLC
    • GABA, Tuesday, April 12, 2016; Event: “Speaker: Karim Dabaggh, PHD, CSO Second Genome; Orli Kadoch, Research and Collaborations Lead, uBiome; Brian Lue, President & CEO NuBiome; Bruno Marchon, PhD, CTO at EpiBiome; Moderator: Katrin Jakob PhD, Co-Founder at White Hawk Software, Founder at California Business Associates
    • JLABS Bay Area, Wednesday Mid Day, April 13, 2016; Topic: “Inspiring Leaders: Derek Herrera – Rebuilding Mind, Body and Business;” Speakers: Derek Herrera | CEO, Spinal Singularity [interviewer]; Renee Ryan | Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC
    •  , Wednesday Evening, April 13, 2016

    You can download details for the above events in a complete PDF list of upcoming events through August 2016 by right clicking on Audreys Picks April 10, 2016. A list of jobs is included in JobsThatCrossedMyDeskThrough April 10, 2016.

    Audrey

Posted by: Audrey Erbes | April 3, 2016

Upcoming Bay Area Bioscience Events Week of April 3, 2016

Highlights of Bay Area Bioscience Events This Coming Week

  • Bio2Device Group, Tuesday Morning, April 5, 2016; Topic: “Microvolution’s Technology Empowers Scientists to Accelerate Medical Research with Greater Accuracy; Speakers: Cassandra Boyer and Marc Bruce, CEO & Co-Founder and CTO & Co-Founder, Microvolution
  • BioX Program Stanford, Thursday Mid Day, April 7, 2016; Topic: “Optical Control and Interrogation of Protein Activity Using Engineered Photoreceptors;” Speaker: Speaker: Bianxiao Cui, Department of Chemistry
  • JLABS, Thursday, April 7, 2016; Event: “Meet with…Sanderling Ventures;” Sanderling Representative: Timothy MillsTimothy Mills | Managing Director, Sanderling Ventures
  • Medtech Frontiers, Thursday Evening, April 7, 2016; Topic: “Exorcising the Silicon Tunnel Vision;” Speaker: Oshiorenoya Agabi, Founder & CEO, Koniku Inc
  • PBSS, Friday, April 8, 2016; Seminar luncheon: “Drug Repurposing for Unmet Medical Needs;” Speakers: Kevin Grimes, MD, MBA (Stanford University)

You can download details for the above events in a complete PDF list of upcoming events through August 2016 by right clicking on Audreys Picks April 3, 2016 A list of jobs is included in JobsThatCrossedMyDeskThrough April 3, 2016.

Audrey

Negative Impact on Workforce and Innovation 

A high level Business Development Executive of Genentech made interesting comment at recent conference that the biotech manpower situation is becoming more like that of high tech. After a product is developed or sold and its source R&D company shut down, all the senior staff and those who worked on the product will go out and do another startup. From on high it appears that all professionals just find another “gig” when the VC investors take their exit. This answer lacks understanding of real world of professionals many of whom lose their position after such an exit event and find it difficult to find place in new start up or other emerging company. There just aren’t enough startups to hire these displaced workers.

The entry of new research professionals into area may be giving the impression that biotech employment is stable in the Bay Area. It may be for the aggregate but not from individual perspective. This high level biotech speaker advised there was no manpower problem in biotech but there was in pharma where layoffs have been common as pharma companies depend more and more on startups to provide them new products

Other panelists saw the situation differently and felt that there was value in research and that this VC game of killing off companies doing research is sabotaging the development of great biotechs that might produce many more products from their focus on scientific research beyond the one shot. One noted there hasn’t been a new Genentech created and that is due to lack of respect for research and relying on the short term chase for profits.

Highlights of Upcoming Week’s Meetings

  • Bio2Device Group, Tuesday Morning, March 29, 2016; Topic: “The Future of Medical Innovation: How Value Based Purchasing (VBP) and Bundled Payments Will Transform the Industry;” Speaker: Ted Kucklick , President and CTO, Cannuflow Inc.
  • JLABS, Tuesday Afternoon, March 29, 2016; Topic: “Choose Your Exit: How to Benefit from IPO Preparation;” Speakers: Matthew Hudes | US Managing Principal, Biotechnology, Deloitte Consulting LLP; Angela Rusakova | West Region Life Sciences Audit Partner, Deloitte & Touche LLP
  • 7th Annual Bay Area Biomedical Device Conference, Wednesday , March 30, 2016
  • ACRP Virtual Career Fair, Thursday Afternoon, March 31, 2016; Event: “Where Clinical Research Talent Meets Opportunity”
  • South Bay HBA, Saturday, April 2, 2016; Location: Shoreline Lake American Bistro – 3160 N Shoreline Blvd., Mountain View, CA

You can download details for the above events in a complete PDF list of upcoming events through August 2016 by right clicking on Audreys PicksMarch 27, 2016 (Autosaved).

Hope you and your family had a relaxing and refreshing holiday.

Audrey

Would the Government Negotiating Drug Prices Be a Good Thing?

The fear of government price controls has prevented changing our market-based health care system to a single payer system like those in Canada and other Western European countries. The assumption has been that innovation would be eliminated. Rather isn’t the question has single payer health care systems proven to destroy drug innovations? Dana Goldman, Ph.D. and director of the USC Leonard D. Schaeffer Center for Health Policy & Economics takes this latter position: “Price controls lower spending, there’s no doubt, but they also reduce research and development. When we reduce research and development spending, we reduce innovation. And when we reduce innovation, we get worse health going forward.” See article at https://medium.com/@CALifeSciences/dana-goldman-q-a-with-clsa-the-downside-of-price-controls-14bd37af9544#.krnaj9tme

John McManus of the McManus Group thinks that the marketplace is already doing a better job of getting the best drug prices than the Secretary of Health and Welfare could do. In his article “Negotiation of Medicare Drug Prices” in the March 2016 issue of LifeScienceLeader.com he notes that the Congressional Budget Office has stated that risk-bearing private plans have strong incentives to negotiate price discounts for … drugs and that the Secretary would not be able to negotiate prices that further reduce federal spending to a significant degree.” See details at http://www.lifescienceleader.com/doc/negotiation-of-medicare-drug-prices-0001

Highlights for Upcoming Life Science Events This Coming Week

  • California Life Sciences Association, Monday-Tuesday, March 21-22, 2016; Event: “Bristol-Myers Squibb Partnering Day; ”Confirmed BMS Participants: Carl Decicco, SVP Discovery;John Houston, SVP Disease Sciences and Biologics; Michael Burgess, SVP Head Exploratory Clinical and Translational Research; Michael Giordano, SVP Head Oncology Development; Douglas Manion, SVP Head Specialty Development; Nils Lonberg, SVP Head Oncology Biology Discovery and BDC; Alan Korman, VP Discovery Immuno-Oncology; Paul Biondi, SVP Business Development
  • Monday March 21, 2016 Networking Cocktail Reception; 4:30pm — 6:30pm; This event, part of the CLSA Partnering Day, will provide a great opportunity to network with BMS Senior R&D and Business Development Leadership.
  • Bio2Device Group, Tuesday Morning, March 22, 2016; Topic: “Successful PR strategies and techniques for emerging medtech companies;” Speaker: Reena Mishra, Senior Director, Marketing , VisionCare Ophthalmic Technologies
  • BioScience Forum, Wednesday Evening, March 23, 2016; Topic: “Development of Pluripotent Stem Cell Based Therapies for Central Nervous System and Oncological Disorders;” Speaker: Jane Lebkowski, Ph.D., President of R&D and Chief Scientific Officer, Asterias Biotherapeutics
  • QB3, Thursday, March 24, 2016; Topic: “Advances In Biologics Development And Delivery;” Moderated by: Prof. Carolyn Bertozzi; Kent Iverson, Biotechnology Consultant and Contractor; Dr. Douglas Crawford, Assoc. Director, QB3; Dr. Greg Bleck, Global Head R&D, Biologic, Catalent Pharma Solutions
  • EPPICON 2016 Conference, Saturday, March 26, 2016; Event: “3D – Convergence of Drug Discovery, Diagnostics and Digital Health”

You can download details for the above events in a complete PDF list of upcoming events through August 2016 by right clicking on Audreys PicksMarch 20, 2016Check out JobsThatCrossedMyDeskThrough March 20, 2016 as well.

Audrey

Older Posts »

Categories

Follow

Get every new post delivered to your Inbox.

Join 103 other followers